ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
approvedEverolimus Tablets for Oral SuspensionAfinitor DisperzPositive
AI Analysis
Summary
ANI Pharmaceuticals received FDA final approval for its ANDA for generic Everolimus Tablets for Oral Suspension (2mg, 3mg, and 5mg), a generic version of Afinitor Disperz.
Outcome Details
FDA approved ANI's ANDA for Everolimus Tablets for Oral Suspension 2mg, 3mg and 5mg, a generic version of Afinitor Disperz
Importance:8/10
Sentiment:
0.90
FDA approvalgeneric drugANDAeverolimus
Related Companies
Read the original article
Published by GlobeNewswire Pharma on September 23, 2026 10:55 AM